Drug Shortage Report for HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)

Last updated on 2022-09-10 History
Report ID 169023
Drug Identification Number 02303108
Brand name HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
Common or Proper name HEPARIN NA
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HEPARIN SODIUM
Strength(s) 10000UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 5ML 10LIVI
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-09
Estimated end date 2022-09-16
Actual end date 2022-09-09
Shortage status Resolved
Updated date 2022-09-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-09-10 English Compare
v4 2022-09-09 French Compare
v3 2022-09-09 English Compare
v2 2022-09-09 French Compare
v1 2022-09-09 English Compare

Showing 1 to 5 of 5